Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EINSTEIN-DVT and PE: Rivaroxaban vs enoxaparin/VKA for acute symptomatic VTE
2006-004495-13Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in deep vein thrombosis (DVT), pulmonary embolism (PE) and venous thromboembolism (VTE) (2 arms), sponsored by Bayer. Started Dec 2006; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2006-004495-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004495-13.